Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early inhaled fluticasone for prevention of bronchopulmonary dysplasia in premature infants
TCTR20210929009Phase 3Unknown
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in bronchopulmonary dysplasia (BPD), sponsored by Faculty of Medicine, Prince of Songkhla University. Status: unknown.
02
Drugs
fluticasone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on TCTR20210929009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210929009.